These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6423286)

  • 21. Comparative in vitro activity of Sch 29,482, a new oral penem, against Neisseria gonorrhoeae.
    Khan MY; Gruninger RP; Nelson SM; Simpson ML
    Antimicrob Agents Chemother; 1983 Mar; 23(3):481-2. PubMed ID: 6405687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neisseria gonorrhoeae, sensitivity of strains isolated in 1976 for amoxicillin, penicillin, cefuroxime, tetracycline and spectinomycin].
    de Koning GA; Stolz E; Michel MF
    Ned Tijdschr Geneeskd; 1979 Jul; 123(28):1199-202. PubMed ID: 157438
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evolution of the sensitivity of the gonococcus to antibiotics. 3].
    Niel G; Nicod G; Roiron V; Durel P
    Pathol Biol (Paris); 1971 Jan; 19(1):53-64. PubMed ID: 4993874
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral rosoxacin for treatment of penicillin-resistant gonorrhoea.
    Harrison WO; Wignall FS; Kerbs SB; Berg SW
    Lancet; 1984 Mar; 1(8376):566. PubMed ID: 6142282
    [No Abstract]   [Full Text] [Related]  

  • 25. [Rosoxacin, a new oral antibiotic used selectively in the treatment of gonorrhea].
    Stapiński A; Dajek Z; Mroczkowski TF; Gede K; Jagielski M; Selibórska Z
    Przegl Dermatol; 1987; 74(3):223-8. PubMed ID: 3122279
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the in-vitro activity of Sch 29482 with thirteen other beta-lactam antibiotics against Neisseria meningitidis and Neisseria gonorrhoeae (including penicillinase-producing isolates).
    Dillon JR; Pauzé M; Yeung H; Bezanson GS
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():175-80. PubMed ID: 6801009
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of subminimal inhibitory concentrations of antibiotics on adherence of Neisseria gonorrhoeae in an experimental model.
    Jacques M; Turgeon PL; Mathieu LG; de Repentigny J
    Exp Biol; 1985; 43(4):251-6. PubMed ID: 3924656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H; Quentin C; de Barbeyrac B; Bebear C
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acrosoxacin in the treatment of uncomplicated gonorrhoea.
    Walsh RJ; Scott R; Bittiner JB; Shahidullah M; Slack RC
    Br J Vener Dis; 1983 Aug; 59(4):242-4. PubMed ID: 6409345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disk diffusion antimicrobial susceptibility testing of Neisseria gonorrhoeae.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 Mar; 39(10):167-9. PubMed ID: 2137900
    [No Abstract]   [Full Text] [Related]  

  • 31. [Management of acute gonorrhea in males with Rosoxacin].
    Fischer-Brügge U; Reinel D
    Dtsch Med Wochenschr; 1985 Jul; 110(28-29):1115-8. PubMed ID: 3924547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic susceptibility testing of Neisseria gonorrhoeae by disk-agar diffusion.
    Riou JY; Guibourdenche M; Courvalin P
    Ann Microbiol (Paris); 1981; 132B(1):23-39. PubMed ID: 6795982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of the sensitivity to antibiotics in strains of Neisseria gonorrhea isolated in Touraine over a 5-year period].
    Pinon G; Quentin R; Laudat P; Vargues R
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):554-6. PubMed ID: 2935773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low antibiotic resistance of gonococci causing disseminated infection.
    Wiesner PJ; Handsfield HH; Holmes KK
    N Engl J Med; 1973 Jun; 288(23):1221-2. PubMed ID: 4633690
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro activities of seven quinolone derivatives against Neisseria gonorrhoeae.
    van der Willigen AH; Degener JE; Vogel M; Stolz E; Wagenvoort JH
    Arzneimittelforschung; 1990 Jun; 40(6):684-5. PubMed ID: 2118763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
    Jones RN; Critchley IA; Whittington WL; Janjic N; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):311-7. PubMed ID: 16269221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative evaluation of the sensitivity of gonococci to oleandomycin, tetracycline and their combinations and experiments in vitro].
    Gulitskaia NI
    Vestn Dermatol Venerol; 1972 Feb; 46(2):68-71. PubMed ID: 4624789
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative study of the sensitivity of gonococci to various antibiotics].
    Lur'e SS; Kvasnaia NI
    Vestn Dermatol Venerol; 1969 Feb; 43(2):46-9. PubMed ID: 4987712
    [No Abstract]   [Full Text] [Related]  

  • 39. [Further increase of quinolone resistance of gonococci in the Netherlands and proposal for a new surveillance].
    Koedijk FD; Borgen K; van Loo IH; van de Laar MJ
    Ned Tijdschr Geneeskd; 2007 Jan; 151(2):142-3. PubMed ID: 17315494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance in gonococci isolated in the WHO Western Pacific Region to various antimicrobials used in the treatment of gonorrhoea, 1997. WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme-WHO WPR GASP.
    Commun Dis Intell; 1998 Dec; 22(13):288-91. PubMed ID: 9893340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.